Keywords: first, pentasaccharide, data, revealed, long-awaited, phase, iib
First pentasaccharide data revealed
Article | 07 September 2000
The long-awaited data from a Phase IIb dose-ranging study ofOrganon/Sanofi-Synthelabo's pentasaccharide, Org 31540/SR90107A, show that it is more ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
